{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:16:10Z","timestamp":1790788570518,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.ijantimicag.2005.08.016","type":"journal-article","created":{"date-parts":[[2005,11,9]],"date-time":"2005-11-09T12:15:49Z","timestamp":1131538549000},"page":"463-472","source":"Crossref","is-referenced-by-count":190,"title":["Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991\u20132003 at a university hospital in Taiwan"],"prefix":"10.1016","volume":"26","author":[{"given":"Po-Ren","family":"Hsueh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwen-Tay","family":"Luh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2005.08.016_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/clinids\/24.2.211","article-title":"Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit","volume":"24","author":"Archibald","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib2","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1128\/AAC.48.7.2431-2436.2004","article-title":"Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002","volume":"48","author":"Flamm","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib3","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijantimicag.2003.05.010","article-title":"Results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme: report of the 2001 data from 15 United States medical centres","volume":"23","author":"Rhomberg","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0732-8893(03)00052-X","article-title":"Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48, 440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997\u20132001)","volume":"47","author":"Sader","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1086\/520193","article-title":"Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals","volume":"29","author":"Fridkin","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib6","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3201\/eid0801.000454","article-title":"Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan","volume":"8","author":"Hsueh","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3201\/eid0801.000454","article-title":"Antimicrobial drug resistance in pathogens causing nosocomial infections at a university hospital in Taiwan, 1981\u20131999","volume":"8","author":"Hsueh","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1089\/10766290152773383","article-title":"Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in intensive care units in 2000 in Taiwan","volume":"7","author":"Hsueh","year":"2001","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib9","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1128\/AAC.47.5.1672-1680.2003","article-title":"Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001","volume":"47","author":"Karlowsky","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1469-0691.2002.00401.x","article-title":"Emerging carbapenemases in gram-negative aerobes","volume":"8","author":"Nordmann","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/jac\/dkg102","article-title":"Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections","volume":"51","author":"Van Eldere","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/jhin.2002.1277","article-title":"Impact of antibiotic changes in empirical therapy on antimicrobial resistance in intensive care unit-acquired infections","volume":"52","author":"Allegranzi","year":"2002","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/j.1875-9114.1995.tb04366.x","article-title":"Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies","volume":"15","author":"Fish","year":"1995","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib14","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s10096-001-8078-8","article-title":"Frequency of isolation and antimicrobial resistance of gram-negative and gram-positive bacteria from patients in intensive care units of 25 European university hospitals participating in the European arm of the SENTRY Antimicrobial Surveillance Program 1997\u20131998","volume":"20","author":"Fluit","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib15","doi-asserted-by":"crossref","unstructured":"Fridkin SK, Edwards JR, Tenover FC, Gaynes RP, McGowan Jr JE; Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Project; National Nosocomial Infections Surveillance (NNIS) System Hospitals. Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections. Clin Infect Dis 2001;33:324\u201330.","DOI":"10.1086\/321893"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0891-5520(05)70388-3","article-title":"The impact of antimicrobial use on the emergence of antimicrobial-resistant bacteria in hospitals","volume":"11","author":"Gaynes","year":"1997","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1067\/mic.2002.124937","article-title":"Analysis of antimicrobial resistance among gram-negative bacilli and antimicrobial use in intensive care unit patients for 5 years in a Veterans Affairs medical center","volume":"30","author":"Gentry","year":"2002","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib18","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/00365540310016646","article-title":"Antibiotic consumption, bacterial resistance and their correlation in a Swiss university hospital and its adult intensive care units","volume":"35","author":"Loeffler","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s15010-003-3201-7","article-title":"Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI)","volume":"31","author":"Meyer","year":"2003","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib20","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/infdis\/152.4.769","article-title":"Occult aminoglycoside resistance in Pseudomonas aeruginosa: epidemiology and implications for therapy and control","volume":"152","author":"Olson","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib21","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1086\/514747","article-title":"Impact of use of multiple antimicrobials on changes in susceptibility of gram-negative aerobes","volume":"28","author":"Friedrich","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1089\/10766290152773392","article-title":"Marked differences in antibiotic use and resistance between university hospitals in Vilnius, Lithuania, and Huddinge, Sweden","volume":"7","author":"Gulbinovic","year":"2001","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections, 1988","volume":"16","author":"Garner","year":"1988","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib24","unstructured":"Anatomical Therapeutic Chemical (ATC) Classification Index with Defined Daily Doses (DDDs) for Plain Substances. Oslo, Norway: WHO Collaborating Center for Drug Statistics and Methodology; 2001."},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib25","unstructured":"National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility test; Approved Standards, eighth ed. M2-A7. Wayne, PA: NCCLS; 2002."},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib26","unstructured":"National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing: 13th Informational Supplement. M100-S13 (M7). Wayne, PA: NCCLS; 2003."},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1469-0691.2005.01098.x","article-title":"Evolution of fluoroquinolone resistance among Escherichia coli urinary tract isolates from a French university hospital: application of the dynamic regression model","volume":"11","author":"Mahamat","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0924-8579(99)00135-1","article-title":"Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis","volume":"14","author":"Lopez-Lozano","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib29","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1128\/AAC.48.2.392-395.2004","article-title":"Replacement of broad-spectrum cephalosporins by piperacillin\u2013tazobactam: impact on sustained high rates of bacterial resistance","volume":"48","author":"Bantar","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0732-8893(01)00296-6","article-title":"Multi-hospital analysis of antimicrobial usage and resistance trends","volume":"41","author":"Lesch","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.289.7.885","article-title":"Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use","volume":"289","author":"Neuhauser","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/clinids\/23.1.118","article-title":"Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center","volume":"23","author":"Rice","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3201\/eid1001.020663","article-title":"Fluoroquinolones protective against cephalosporin resistance in gram-negative nosocomial pathogens","volume":"10","author":"Schwaber","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2005.08.016_bib34","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1093\/clinids\/24.Supplement_1.S139","article-title":"Control of nosocomial antimicrobial-resistant bacteria: a strategic priority for hospitals worldwide","volume":"24","author":"Goldmann","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib35","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1086\/432056","article-title":"Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals","volume":"41","author":"MacDougall","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/313916","article-title":"Assessment of the relationship between antimicrobial usage and susceptibility: differences between the hospital and specific patient-care areas","volume":"31","author":"White","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2005.08.016_bib37","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1086\/431980","article-title":"Hospital-level rates of fluoroquinolone use and the risk of hospital-acquired infection with ciprofloxacin-nonsusceptible Pseudomonas aeruginosa","volume":"41","author":"Ray","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"4 Suppl.","key":"10.1016\/j.ijantimicag.2005.08.016_bib38","doi-asserted-by":"crossref","first-page":"N128","DOI":"10.1097\/00003246-200104001-00013","article-title":"Infection control measures to limit antimicrobial resistance","volume":"29","author":"Warren","year":"2001","journal-title":"Crit Care Med"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485790500261X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485790500261X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T15:00:15Z","timestamp":1706713215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485790500261X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S092485790500261X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2005.08.016","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}